MedTrace Logo

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

NCT00355719 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-12-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the influence of nevirapine in exposure to atazanavir boosted with ritonavir, in steady state equilibrium, in HIV-infected adult patients.

Conditions

  • HIV Infections

Interventions

DRUG

Atazanavir (Reyataz)

Atazanavir (Reyataz): capsules 150 mg (2 capsules/24h)

DRUG

Ritonavir (Norvir)

Ritonavir (Norvir): capsules 100 mg (1 capsule/24h)

DRUG

Nevirapine (Viramune)

Nevirapine (Viramune): tablets 200 mg (1 tablet/12h\*)

Sponsors & Collaborators

  • Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

    collaborator OTHER

  • Hospital San Jaime de Calella

    collaborator UNKNOWN

  • Germans Trias i Pujol Hospital

    lead OTHER

Principal Investigators

  • Bonaventura Clotet, MD,PhD · LLuita contra la Sida Foundation-HIV Unit

  • Jose Molto, MD,PhD · LLuita contra la Sida Foundation-HIV Unitat

  • Josep Mª LLibre, MD,PhD · Lluita contra la Sida Foundation- HIV Unit

  • Sílvia Valero · Hospital Sant Jaume de Calella

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00355719 on ClinicalTrials.gov